A 45-minute panel discussion on recent findings of gadolinium deposition in patients who have undergone contrast-enhanced MRI. Being held May 21 at noon in the Grand Ballroom, as part of the America Society of Neuroradiology annual meeting.
Gadolinum Deposition and the Safety of MRI Contrast Agents
May 20th, 2016Dec 31st, 1969
Latest in Home
Bone-RADS improves accuracy for junior, attending physicans
October 17, 2025
PET/CT reveals ‘chemo brain’ regions in leukemia patients
October 16, 2025